Licht P, Gallo A B, Aggarwal B B, Farmer S W, Castelino J B, Papkoff H
J Endocrinol. 1979 Dec;83(3):311-22. doi: 10.1677/joe.0.0830311.
The biological and binding activities of pregnant mare serum gonadotrophin (PMSG) were compared with those of highly purified FSH and LH from the pituitary gland of the same species. Pregnant mare serum gonadotrophin showed activity in bioassays considered to be specific for both FSH (e.g. the Steelman-Pohley ovarian augmentation test and cyclic AMP production by rat seminiferous tubules) and LH(androgen production by rat Leydig cells), as well as activity in a variety of radioreceptor assay systems previously considered to be specific for one of the two types of gonadotrophin. The potency of PMSG was high compared with that of purified ovine FSH or LH standards in all assays but PMSG was considerably less active than equine FSH and LH in vitro. In radioreceptor assays employing rat, pig and horse tissues, the activity of PMSG was equivalent to only 1--5% of equine FSH in competing for FSH-binding sites and only 3--35% of equine LH in competing for LH-binding sites. Pregnant mare serum gonadotrophin was least active in homologous binding assays with horse testis and equine LH as radioligand. In the rat Leydig cell bioassay, the activity of PMSG was only 2.0% that of equine LH. Furthermore, in some assays equine LH was found to resemble PMSG in exhibiting a high degree of FSH-like activity that could not be accounted for by cross-contamination. The FSH immunoactivity of equine LH was less than 0.5% that of equine FSH, but equine LH was up to 63% as potent as equine FSH in competition for FSH-binding sites and it was 20% as active in the Steelman-Pohley ovarian augmentation bioassay. Equine LH did not, however, show the expected activity in the cyclic AMP production bioassay. Thus, the FSH-binding sites and physiological receptors may not be identical. Overall, comparison of PMSG with pituitary gonadotrophins from homologous species shows that the apparent dual activity of PMSG may not be a unique feature of this pregnancy hormone since equine LH also exhibits some FSH activities. The chemical resemblance between PMSG and equine LH is noteworthy in this regard.
将孕马血清促性腺激素(PMSG)的生物学活性和结合活性与来自同一物种垂体的高度纯化的促卵泡激素(FSH)和促黄体生成素(LH)进行了比较。孕马血清促性腺激素在被认为对FSH(如斯蒂尔曼 - 波赫利卵巢增重试验以及大鼠生精小管产生环磷酸腺苷)和LH(大鼠睾丸间质细胞产生雄激素)具有特异性的生物测定中均表现出活性,同时在各种先前被认为对两种促性腺激素之一具有特异性的放射受体测定系统中也具有活性。在所有测定中,与纯化的绵羊FSH或LH标准品相比,PMSG的效价较高,但在体外,PMSG的活性远低于马的FSH和LH。在使用大鼠、猪和马组织的放射受体测定中,PMSG在竞争FSH结合位点时的活性仅相当于马FSH的1% - 5%,在竞争LH结合位点时的活性仅相当于马LH的3% - 35%。在以马睾丸和马LH作为放射性配体的同源结合测定中,孕马血清促性腺激素的活性最低。在大鼠睾丸间质细胞生物测定中,PMSG的活性仅为马LH的2.0%。此外,在一些测定中发现马LH在表现出高度的FSH样活性方面与PMSG相似,而这种活性无法用交叉污染来解释。马LH的FSH免疫活性不到马FSH的0.5%,但在竞争FSH结合位点时,马LH的效力高达马FSH的63%,在斯蒂尔曼 - 波赫利卵巢增重生物测定中的活性为马FSH的20%。然而,马LH在环磷酸腺苷产生生物测定中并未表现出预期的活性。因此,FSH结合位点和生理受体可能并不相同。总体而言,将PMSG与同源物种的垂体促性腺激素进行比较表明,PMSG明显的双重活性可能并非这种妊娠激素的独特特征,因为马LH也表现出一些FSH活性。在这方面,PMSG与马LH之间的化学相似性值得注意。